Gibson Dunn Reps Accuray In $277M Radiotherapy Deal
By Sherry Mazzocchi · March 7, 2011, 7:25 PM EST
California radiation oncology company Accuray on Monday announced plans to buy TomoTherapy Inc. for $277 million, creating a new global cancer treatment provider expected to pull in annual revenue of more...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login